Metamark Genetics Raises $22 Million
Metamark Genetics Inc., a Cambridge, Mass.-based molecular diagnostics company focused on cancer, has raised $22 million in Series B funding. No investor information was disclosed.
14 July 2010•3 mins read
Metamark Genetics Inc., a Cambridge, Mass.-based molecular diagnostics company focused on cancer, has raised $22 million in Series B funding. No investor information was disclosed.
